Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4705)
All Articles published online
|
Publishing Process of This Article
|
Aug 15, 2024 (publication date) through Oct 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Fernandez CJ, Shetty S, Pappachan JM. Diabetic cardiomyopathy: Emerging therapeutic options. World J Diabetes 2024; 15(8): 1677-1682 [PMID: 39192854 DOI: 10.4239/wjd.v15.i8.1677] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Fernandez CJ, Shetty S, Pappachan JM. Diabetic cardiomyopathy: Emerging therapeutic options. World J Diabetes 2024; 15(8): 1677-1682 [PMID: 39192854 DOI: 10.4239/wjd.v15.i8.1677] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v15/i8/1677.htm |
| Number | Citing Articles |
| 1 |
L. A. Ruyatkina, D. S. Ruyatkin. Spectrum of effects of dipeptidyl peptidase-4 inhibitors: within and beyond glycemic control (part 1). Diabetes mellitus 2025; 28(4): 404 doi: 10.14341/DM13342
|
| 2 |
Francisco Epelde. Impact of DPP-4 Inhibitors in Patients with Diabetes Mellitus and Heart Failure: An In-Depth Review. Medicina 2024; 60(12): 1986 doi: 10.3390/medicina60121986
|
| 3 |
Xiaofang Dan, Ke Li, Jiali Xu, Pijun Yan. The Potential of Neuregulin 4 as a Novel Biomarker and Therapeutic Agent for Vascular Complications in Type 2 Diabetes Mellitus. Journal of Inflammation Research 2024; : 8543 doi: 10.2147/JIR.S492115
|